Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac β-adrenoceptor system in experimental heart failure

Circulation Research

Volumn 91, Issue 11, 2002, Pages 1056-1062

  Leineweber, Kirsten ^a,b   Brandt, Katja ^a   Wludyka, Beate ^a   Beilfuß, Anja ^a   Pönicke, Klaus ^a   Heinroth Hoffmann, Ingrid ^a   Brodde, Otto Erich ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

adrenoceptor; G protein coupled receptor kinase; Monocrotaline; Neurohumoral activation; Right heart hypertrophy

Indexed keywords

BETA ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; MONOCROTALINE; NEUROHORMONE; NORADRENALIN; NORADRENALIN TRANSPORTER; RHODOPSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; DISEASE MODELS, ANIMAL; EYE PROTEINS; FLUOXETINE; HEART FAILURE, CONGESTIVE; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MONOCROTALINE; MYOCARDIUM; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGAN SIZE; PROTEIN KINASES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, NEUROTRANSMITTER; RHODOPSIN; RHODOPSIN KINASE; SYMPORTERS;

EID: 0037195728     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000045088.59360.B7     Document Type: Article

References (32)

1. 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
2. 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol. 1986;8:1235-1242.
3. 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 1989;35:295-303.
4. Brodde O-E, Vogelsang M, Broede A, Michel-Reher M, BeisenbuschSchäfer E, Hakim K, Zerkowski H-R. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: No difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol. 1998;31:585-594.
5. 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454-463.
6. Böhm M, La Rosee K, Schwinger RHG, Erdmann E. Evidence for a reduction in norepinephrine uptake sites in the failing human hearts. J Am Coll Cardiol. 1995;25:146-153.
7. Yoshi H, Tobise K, Onodera S. Intraventricular changes in the β-adrenoceptor-adenylate cyclase system of the rat heart with the progress of monocrotaline-induced right ventricular hypertrophy. Jap Circ J. 1994;58:855-865.
8. Seyfarth T, Gerbershagen HP, Giessler C, Leineweber K, Heinroth-Hoffmann I Pönicke K, Brodde O-E. The cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats. J Moll Cell Cardiol. 2000;32:2315-2326.
9. Abraham G, Seyfarth T, Heinroth-Hoffmann I, Brodde O-E. β-adrenoceptors in cardiomyocytes from monocrotaline-treated rats. Naunyn-Schmiedebergs Arch Pharmacol. 2001;363(suppl):374. Abstract.
10. 1) in right ventricles of monocrotaline-treated rats. Br J Pharmacol. 2000;131:1438-1444.
11. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler M, Ginsburg R. β-adrenergic neuroeffector abnormalities in the failing human heart are produced by a local rather than systemic mechanisms. J Clin Invest. 1992;89:803-815.
12. Ceconi C, Condorelli E, Quinzanini M, Rodella A, Ferrari R, Harris P. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. Cardiovasc Res. 1989;23:674-682.
13. 2-receptors are differentially desensitized in an experimental model of heart failure. J Cardiovasc Pharmacol. 1990;16:839-846.
14. 1-adrenergic vascular reactivity in monocrotaline-treated rats. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:87-95.
15. Tatebe S, Miyamura H, Sugawara M, Watanabe H, Eguchi S. Induction of right ventricular hypertrophy in neonatal guinea pigs by monocrotaline. Jpn Circ J. 1996;60:604-608.
16. Schäfers RF, Poller U, Pönicke K, Geissler M, Daul AE, Michel MC, Brodde O-E. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:239-249.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
18. 2-adrenoceptors. Eur J Pharmacol. 1986;130:137-139.
19. Leineweber K, Heinroth-Hoffmann I, Pönicke K, Abraham G, Osten B, Brodde O-E. Cardiac β-adrenoceptor desensitization due to increased β-adrenoceptor kinase activity in chronic uremia. J Am Soc Nephrol. 2002;13:117-124.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
21. Reissner AH, Nemes P, Buchholtz C. The use of Coomassie brilliant blue G-250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. Anal Biochem. 1975;64:509-516.
22. Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res. 1999;85:1101-1111.
23. Lau YH, Robinson RB, Rosen MR, Bilezikian JP. Subclassification of β-adrenergic receptors in rat cardiac myoblasts and fibroblasts. Circ Res. 1980;47:41-48.
24. 2-adrenoceptors in guinea-pigs and rats are located on the coronary endothelium. Naunyn Schmiedebergs Arch Pharmacol. 1986;334:56-62.
25. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-17229.
26. Goldstein DS. Plasma catecholamines and essential hypertension: An analytical review. Hypertension. 1988;5:86-99.
27. Francis GS, Cohn JN. The autonomic nervous system in congestive heart failure. Ann Rev Med. 1986;37:235-247.
28. Delehanty JM, Himura Y, Elam E, Hood WB Jr, Liang CS. β-adrenoceptor down-regulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol. 1994;266:H930-H935. (Heart Circ Physiol. 35)
29. Dong E, Yatani A, Mohan A, Liang CS. Myocardial β-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol. 1999;384:17-24.
30. Iaccarino G, Koch WJ. Therapeutic potential of G-protein coupled receptor kinases in the heart. Exp Opin Invest Drugs. 1999;8:545-554.
31. 1-adrenergic receptor: Involvement of GRKs and cAMP-dependent protein kinase. J Biol Chem. 1995;270:17953-17961.
32. De Blasi A, Parruti G, Sallese M. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes: Selective increase of β-adrenergic receptor kinase 1 and 2. J Clin Invest. 1995;95:203-210.